(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

CLOSED LOOP MEDICINE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

CLOSED LOOP MEDICINE

ST13

US500000079304829

Classe

5, 9, 10, 42, 44

Pedido

79304829

Registro

6624357

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

28

Atualização mais recente

01/08/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 10, 42, 44

Data de depósito

15/09/2020

Data de registro

25/01/2022

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

25/01/2022

Última transação

25/01/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

CLARK, ROBERT C

Unidade examinadora

L10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

CLOSED LOOP MEDICINE LTD

Representantes

Richard S. Finkelstein RC Trademark Company, LLC

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of sleep disordershypertensionchronic painmetabolic diseasemental healthanxietydepressionpsychosisendocrine conditionsthyroid disordersinflammatory disorderspolymyalgia rheumatica; Medical preparations for the treatment of sleep disordershypertensionchronic painmetabolic diseasemental healthanxietydepressionpsychosisendocrine conditionsthyroid disordersinflammatory disorderspolymyalgia rheumatica; pain relief medication; medicines for the treatment of sleep disturbance; medicines for the treatment of hypertension; medicines for the treatment of metabolic disorders

Classe 9

Downloadable computer software for facilitating optimisation of drug dosage and patient instruction; Downloadable communication software for providing access to the Internet; Downloadable software for data processing; Downloadable computer application software for mobile phonesportable media playershandheld computerssoftware for facilitating optimisation of drug dosage and patient instruction; Downloadable cloud-computing software for deploying virtual machines to a cloud computing platformmanaging virtual machines on a cloud computing platform; ; Downloadable interface software for facilitating optimisation of drug dosage and patient instruction; Downloadable application programming interface (API) software; Downloadable computer application software for mobile phonessoftware for facilitating dose optimisation and patient instruction; Downloadable mobile applications for facilitating optimisation of drug dosage and patient instruction; Downloadable computer software using artificial intelligence for use in software developmentmachine learningfacial and speech recognition for facilitating optimisation of drug dosage and patient instruction; humanoid robots with artificial intelligence; cloud computing software; RAM (random access memory) card; Computer programsrecordedfor facilitating optimisation of drug dosage and patient instruction; Downloadable computer software using artificial intelligence for data analysis; Downloadable computer software using artificial intelligence for facilitating optimisation of drug dosage and patient instruction; Downloadable computer software for machine learning; computer hardware; data processing apparatus; Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying data; wearable activity trackers; parts and fittings for all of the aforesaid goods

Classe 10

Medical apparatus and instrumentsnamely blood pressure monitorthermometers for medical usethermometers for medical purposes; Medical diagnostic apparatus for testing testing urine sulfatoxymelatonin levelssaliva cortisol levelsblood sugar levels; Apparatusinstruments and devices for measuringmonitoring and recording body vital health parametersbody composition analyzers for medical purposesheart rate monitorsblood pressure monitorspulse oximeters; Medical apparatus and instruments for monitoring blood oxygen saturationblood gas concentrationsvital signs and respiratory eventsrecorded software for recordingprocessing and transmitting medical datafor use therewithsold as a unit; Electronic temperature monitors for medical use; Electronic monitors for medical use for oximetry measurementsleep monitorscough characteristic monitorsblood pressureheart ratetemperature sensors.; parts and fittings for all of the aforesaid goods

Classe 42

Scientific and technological servicesscientific researchanalysistesting in the field of healthcarepharmaceutical drugsdrug or digital therapeutic optimisationclinical pathway optimisation and reimbursement strategies; Scientific research in the field of healthcarepharmaceutical drugsdrug or digital therapeutic optimisationclinical pathway optimisation and reimbursement strategies; scientific research relating to medicine; scientific research relating to pharmaceuticals; research and development services relating to medicine; research and development services relating to pharmaceuticals; research and development services relating to drugs; research and development services relating to healthcare; providing medical and scientific research information in the field of pharmaceuticals and medicine; Providing scientific information in the field of healthcarepharmaceutical drugsdrugsdrug or digital therapeutic optimisationclinical pathway optimisation and reimbursement strategies; Software as a service (SAAS) services featuring software for the collectionmanagement and processing of data and multimedia files and communication in the field of healthcarepharmaceutical drugs; Platform as a service (PAAS) featuring computer software platforms for the collectionmanagement and processing of data and multimedia files and communication in the field of healthcarepharmaceutical drugsdrug or digital therapeutic optimisationclinical pathway optimisation and reimbursement strategies; data-as-a-service (DAAS) services featuring software for the collectionmanagement and processing of data and multimedia files and communication in the field of healthcarepharmaceutical drugsdrug or digital therapeutic optimisationclinical pathway optimisation and reimbursement strategies; providing information and data relating to scientific and technological research and developmentscientific researchanalysistesting in the field of healthcarepharmaceutical drugsdrug or digital therapeutic optimisationclinical pathway optimisation and reimbursement strategies; design and development of computer software; updating and maintenance of computer software; Computer programming in the medical field; Compiling data for research purposes in the field of medical science and medical consultancy; information and advisory related to all of the aforesaid services

Classe 44

Healthcare; health consultancy; healthcare services; healthcare information services; healthcare advisory services; health clinical services; Health screening services in the field of sleep disordershypertensionchronic painmetabolic diseasemental healthanxietydepressionpsychosisendocrine conditionsthyroid disordersinflammatory disorderspolymyalgia rheumatica; medical health assessment services; physical therapy services; Medical monitoring services; individual medical counseling services provided to patients; medical care services relating to patient treatment; health counselling; Health screening services in the field of sleep disordershypertensionchronic pain and metabolic diseasemental healthanxietydepressionpsychosisendocrine conditionsthyroid disordersinflammatory disorderspolymyalgia rheumatica; Providing medical information to patientsmedical professionals in the form of reports in the field of sleep disordershypertensionchronic painmetabolic diseasemental healthanxietydepressionpsychosisendocrine conditionsthyroid disordersinflammatory disorderspolymyalgia rheumatica; providing medical information; information and advisory related to all of the aforesaid services

Publicações

Histórico de despachos e eventos da marca no USPTO.

28 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/08/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/07/2022

FIMP

FINAL DISPOSITION PROCESSED

07/07/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

25/04/2022

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/04/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

25/01/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/11/2021

PUBO

PUBLISHED FOR OPPOSITION

09/11/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

20/10/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/10/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/10/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/10/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

06/10/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

16/09/2021

GNFR

FINAL REFUSAL E-MAILED

16/09/2021

CNFR

FINAL REFUSAL WRITTEN

16/09/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/09/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/09/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/09/2021

RFNT

REFUSAL PROCESSED BY IB

05/04/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/03/2021

RFRR

REFUSAL PROCESSED BY MPU

15/03/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/03/2021

CNRT

NON-FINAL ACTION WRITTEN

08/03/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/03/2021

DOCK

ASSIGNED TO EXAMINER

01/03/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/03/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

25/02/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace CLOSED LOOP MEDICINE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.